G

Grifols SA

D
GRFS
USD
0.45
(4.9614%)
مفتوح الان
36,715.00
حجم التداول
0.51
الربح لكل سهم
-
العائد الربحي
37.524
P/E
6,470,069,974.48
حجم السوق
اليوم
4.9614%
1 اسبوع
5.135%
1 شهر
10.698%
6 اشهر
30.500%
12 اشهر
6.966%
بداية السنة
-17.647%
كل الوقت
-40.388%

Title:
Grifols SA

Sector:
Healthcare
Industry:
Drug Manufacturers - General
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.
هل تحتاج مساعدة او لديك استفسار؟